Free Virtual Conference – Genomics & Precision Medicine

Among the best investments ever made in a technology has been the ability to sequence, annotate, and make functional associations of genes for therapeutic indications – in short, the whole field of genomics and precision medicine. We see the pay-off today in the rapid sequencing of the SARS Cov-2 RNA genome, the rapid development of vaccines, and the current tracking of the coronavirus variants in near-real time. While genomics continues to play a role for developing effective, targeted drugs for cancers, its impact has been expanding to impact other therapeutic areas and diseases with a new generation of assays and medicines for personalized therapeutic regimens.

If you are a genomics researcher, clinical scientist, practicing clinician, or in regulatory affairs, this conference is one you cannot miss. Please join us for the world’s most informative conference for genomics and precision medicine leaders from academia, biotech, pharmaceuticals, diagnostics, clinical research, healthcare and regulatory bodies.

We invite you to join us in for the Genomics & Precision Medicine Virtual Summit with a line-up of speakers who will address these points and more:

Clinical data in the era of precision medicine
Genetics/Genomics Platforms
Genomic annotation and association studies in Clinical Science
Proteomics/Protein-based Assays
The Economics of drug vigilance based on pharmacogenetics
Positioning drugs tied to pharmacogenetics for coverage by payers
Tracking and evaluating data through telehealth for rapid collections of vigilance data
Who should attend:

Executives and Decision Makers – CEOs, CTOs, CMOs, and CSOs
Leaders in clinical genomics, biomarkers, assays
Clinical trial planning and operations
Clinical Research, Development, Translational Medicine
Practicing Clinicians
Genomics/Genetics Analysts
Regulatory Leaders in Government and Business Affairs groups
Economic Planners and Forecasters
Marketing Leaders
Business Development Managers
Biotech and Biomedical technology researchers
Government and public support agencies